Navigation Links
HA&W Obtains Approximately $2 M in Credits and Cash Grants for Clients Through the Therapeutic Discovery Project Program

ATLANTA, Nov. 18, 2010 /PRNewswire/ -- Habif, Arogeti & Wynne (HA&W) is pleased to announce that it obtained approximately $2 million in credits and cash grants for qualified clients through the Therapeutic Discovery Project Program (TDPP).  The TDPP was created by the Patient Protection and Affordable Care Act in March 2010 with $1 billion allocated for credits and grants to qualifying projects in increments of up to $5 million.  One hundred percent of HA&W clients who received assistance in applying for grants received an award.

Awards were granted primarily to pharmaceutical companies working on qualified therapeutic drugs that met specific federal healthcare and economic guidelines.

Soon after the passage of this Act, HA&W moved quickly to identify clients who met the complicated eligibility requirements.  This process was made easier due the Firm's Technology & Life Sciences Practice and its well-established R&D practice area.  Based on these relationships, HA&W's staff qualified candidates and worked closely with them to explain the requirements in detail.  As a result, all clients for whom HA&W prepared an application were awarded cash grants or tax credits.

HA&W Partner and Technology & Life Science Practice leader, Mitchell Kopelman, said, "We knew we had a limited window of opportunity to help our clients take advantage of this program.  Our expertise in the R&D tax credits and our close relationships with our clients allowed us to quickly identify those with the best chances and help them with the application process.  I'm proud of our staff and their effort, and I'm very happy for our clients."

In total, 5,600 companies applied for the award by the deadline in July.  A total of 4,606 projects from 2,923 companies were deemed eligible for the award and the recipients were contacted on October 29th.  Fifty-one of the companies are in Georgia.  While the maximum award allowed was $5 million per applicant, the IRS capped the award at $244,479 per project due to the overwhelming number of applicants.

Habif, Arogeti & Wynne, LLP is the largest independent accounting and business advisory firm headquartered in Georgia and one of the top 50 firms in the United States. The firm's more than 300 professionals provide financial solutions – including accounting, auditing and tax services, forensic and litigation services, management consulting, financial planning, technology consulting and financial staffing – to more than 5,000 clients in a variety of industries. HA&W serves its expanding list of international clients through its membership in Baker Tilly International, an association of leading independent accounting firms worldwide. For more information on HA&W, visit

SOURCE Habif, Arogeti & Wynne, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Sky One Medical Obtains SFDA Approval for Ciclopirox Olamine Vaginal Suppositories
2. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
3. Par Obtains Exclusive Rights to Market and Distribute Generic Zetia(R) in the U.S.
4. Sanofi-aventis Obtains Antitrust Clearance in Connection With Chattem, Inc. Tender Offer
5. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
6. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
7. Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
8. Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections
9. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
10. Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government
11. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
Post Your Comments:
(Date:11/25/2015)... 2015 --> ... Lizenz für das Patent über eine neue Hepatitis-B-Behandlung, welches ... innehaben, an Enyo Pharma vergeben haben. Im ... gerufenen und von Edelris gemeinsam mit seinen Partnern Inserm ... für HBV identifiziert, und es wurden neue Inhaltsstoffe entdeckt, ...
(Date:11/24/2015)... , Nov. 25, 2015 WuXi PharmaTech ... ), a leading open-access R&D capability and technology platform ... with operations in China and ... that at an extraordinary general meeting of shareholders held ... proposal to authorize and approve the previously announced agreement ...
(Date:11/24/2015)... Nov. 24, 2015  Array BioPharma Inc. (Nasdaq: ... Executive Officer, Ron Squarer , will present ... New York.  The public is welcome to participate ... Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  , ... 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... November 25, 2015 , ... ... Their Care Plan software creates an agreement between the practice owner and ... including financial, scheduling, monitoring, notification, and projections. Click here to ...
(Date:11/24/2015)... ... November 24, 2015 , ... Charitable giving is at its peak during ... the last five weeks of the year totalling over $358 billion in 2014. ... the nation’s charities with those individuals who want to “give back” during the holidays. ...
(Date:11/24/2015)... ... 2015 , ... The hospitals and health systems on this ... care. They have received recognition for excellence from various reputable organizations in areas ... Hospital Review selected hospitals for inclusion based on national rankings and awards from ...
(Date:11/24/2015)... ... 2015 , ... In response to recent news highlighting Oxycodone fraud, Novus Medical ... the United States grew 400 percent between 1999 and 2010, far more than the ... percent of all fatal drug overdoses. (1) , While oxycodone and the extended release ...
(Date:11/24/2015)... ... , ... Serenity Point Rehabilitation, a holistic treatment center for substance abuse located ... the staff members at their recovery center. The videos highlight some of the various ... the things that make their recovery program so unique. , “Making the decision to ...
Breaking Medicine News(10 mins):